The molecular underpinnings of the immune landscape in prostate cancer: decoding a “cold” tumor
Prostate cancer (PCa) remains a leading cause of cancer-related death in men, characterized by a notoriously immunosuppressive tumor microenvironment (TME) that renders it largely refractory to immune checkpoint inhibitors (ICIs). This “cold” tumor phenotype is orchestrated by a complex network of molecular mechanisms,...